Frontlight ResearchEarly access
CompletedPhase 1
Feasibility of a Digital Therapeutic for Adults With Posttraumatic Stress Disorder (PTSD)
Key facts
- Who runs it
- Oui Therapeutics, Inc.
- Where
- Tallahassee, United StatesSee the site
- Trial code
- Status
- Completed
- Phase
- Phase 1
- People taking part
- 40 people enrolled
- Started
- 30 Jun 2025
- Ended
- 21 Nov 2025
- Type of study
- Interventional, 2 groups
- Treatments tested
- OTX-601 Digital Therapeutic - Version 1
- OTX-601 Digital Therapeutic - Version 2
- Treatment as Usual (TAU)
- Record updated
- 27 July 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Posttraumatic stress disorder (PTSD) diagnosis
- Anxiety Sensitivity Index 3 (ASI-3) scores above 24
- PTSD Checklist for DSM-V (PCL-5) scores above 30
- Understands and speaks English
- Access to a smartphone that is connected to the internet
Who cannot take part
- Medical illness that would prevent the completion of interoceptive exposure exercises
- Score of 24 or lower on the ASI-3
- Score of 30 and below on the PCL-5
- No PTSD diagnosis
- Active psychosis
- Acute intoxication during study baseline
- Enrolled in another treatment research study
Where in United States
- Florida State UniversityTallahassee, United States
About the trial
What the trial wants to find out
This study is exploring the efficacy of a digital therapeutic app in reducing symptoms of posttraumatic stress disorder (PTSD) in adults.
The 2 groups in the trial
- OTX-601 Digital Therapeutic - Version 1Treatment being tested
A prescription digital therapeutic designed to overcome existing barriers and deliver evidence-based treatment for PTSD
Treatment: OTX-601 Digital Therapeutic - Version 1 and Treatment as Usual (TAU)
- OTX-601 Digital Therapeutic - Version 2Treatment being tested
Increased dose of a prescription digital therapeutic designed to overcome existing barriers and deliver evidence-based treatment for PTSD
Treatment: OTX-601 Digital Therapeutic - Version 2 and Treatment as Usual (TAU)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Dosage, Feasibility, Acceptability and Usability of OTX-601
- Record updated
- 27 July 2026